Nivolumab Improves Survival in Patients with Relapsed Malignant Mesothelioma. | EBSCOhost

Connecting you to content on EBSCOhost

Title: Nivolumab Improves Survival in Patients with Relapsed Malignant Mesothelioma.
Authors: Ackerman, William
Publication: Oncology Practice Management, 2021, Vol 11, Issue 5, p1
ISSN: 2164-4403
Publication type: Periodical